Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition of the Advanced Diabetes Supply Group, a leading national direct-to-patient provider of diabetes medical supplies, to accelerate Cardinal Health's at-Home Solutions growth strategy Company announces plan to hold Investor Day in June 2025 DUBLIN, Ohio, Nov. 11, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) annou ...

Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...

Core Insights - Cardinal Health reported better-than-expected first-quarter profit and sales, driven by growing demand from existing customers [1] - Despite a revenue decline in its largest division, Pharmaceutical & Specialty Solutions, the company indicated that revenue would have increased by 16% year-over-year without the loss of a significant contract [1] - The company raised its full-year EPS guidance, and its shares reached a new all-time intraday high [1] Financial Performance - The company reported fiscal 2025 first-quarter adjusted earnings per share (EPS) of $1.88, exceeding analyst forecasts [1] - Revenue decreased by 4% year-over-year to $52.28 billion, but still surpassed consensus estimates [1] - Sales in the Pharmaceutical and Specialty Solutions unit fell by 5% to $48.0 billion due to the expiration of a distribution contract with OptumRx; however, excluding this impact, revenue would have increased by 16% [1] Segment Performance - Revenue in the Global Medical Products and Distribution segment rose by 3% to $3.1 billion, attributed to higher volumes from existing customers [1] - Other revenue surged by 13% to $1.2 billion, driven by "at-Home Solutions, Nuclear and Precision Health Solutions, and OptiFreight Logistics" [1] Future Outlook - Cardinal Health now projects full-year EPS in the range of $7.75 to $7.90, an increase from the previous guidance of $7.55 to $7.70 [1] - Following the earnings report, shares of Cardinal Health increased nearly 7% to $115.76, with an earlier peak of $119.12 [1]

Cardinal Health, Inc. (NYSE:CAH) Q1 2025 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Erin Wright - Morgan Stanley Eric Percher - Nephron Research Allen Lutz - Bank of America Kevin Caliendo - UBS Eric Coldwell - Baird George Hill - Deutsche Bank Stephanie Davis - Barclays Eli ...

Cardinal Health, Inc.(CAH) reported first-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.88, which beat the Zacks Consensus Estimate of $1.64 by 9.8%. The bottom line also improved 9.3% year over year.GAAP EPS in the quarter was $1.70 against a loss of 5 cents per share in the year-ago period.Revenue DetailsSales declined 4.3% on a year-over-year basis to $52.28 billion. However, the top line beat the Zacks Consensus Estimate by 2%.Segmental AnalysisPharmaceutical and Specialty Solutions Pharma ...

For the quarter ended September 2024, Cardinal Health (CAH) reported revenue of $52.28 billion, down 4.5% over the same period last year. EPS came in at $1.88, compared to $1.73 in the year-ago quarter. The reported revenue represents a surprise of +1.99% over the Zacks Consensus Estimate of $51.26 billion. With the consensus EPS estimate being $1.64, the EPS surprise was +14.63%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to det ...

| --- | --- | --- | --- | |-------|------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | Q1 FY25 Earnings | | | • Q1 FY25 Earnings Cautions Concerning Forward-Looking Statements This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "c ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ | --- | --- | |--------------------------------------------------------------------------------------|------------------------ ...

Cardinal Health (CAH) came out with quarterly earnings of $1.88 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.73 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.63%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $1.72 per share when it actually produced earnings of $1.84, delivering a surprise of 6.98%.Over the last four qu ...

Exhibit 99.1 FOR IMMEDIATE RELEASE Cardinal Health Reports First Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook • Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration • GAAP operating earnings were $568 million; GAAP diluted EPS was $1.70 • Non-GAAP operating earnings increased 12% to $625 million, driven by significant growth in Pharmaceutical and Specialty Solutions segment profit • Non-GAA ...